Global Soft Tissue Allografts Market: Snapshot
The global market for soft tissue allografts has a prosperous future, and is projected to experience incrementing demand at a CAGR of 6.3% during the forecast period of 2017 to 2025. The global soft tissue allografts market is estimated to reach a valuation of US$6.2 bn by the end of 2025, considerably up from its evaluated worth of US$3.6 bn in 2016. Increasing geriatric population who frequently need orthopedic assistance, growing demand of soft tissue allografts among athletes, escalation in anterior cruciate ligament (ACL) reconstruction surgeries, and requirement for cares of diabetes-caused foot ulcer are some of the key factors augmenting demand in the global soft tissue allografts market. On the other hand, high cost of these procedures and a few perceived complications are hindering the soft tissue allografts market from attaining its true potential.
Collagen Allografts Dominates Demand
On the basis of the type of soft tissue allograft, the market for the same has been segmented into cartilage allograft, collagen allograft, tendon allograft, meniscus allograft, dental allograft, and amniotic allograft. While cartilage allograft has been further sub-segmented into hyaline cartilage, elastic cartilage, and fibro cartilage, the tendon allograft segment has been classified into achilles tendon, tibialis, and patellar tendon. The collagen allografts segment dominated the global soft tissue allografts market in 2016, accounting for the most prominent market share in 2016 as these devices are mostly utilized by the vascular and orthopedic surgeons for treatment of diabetic foot ulcers, ACL surgeries, and other cosmetic surgeries. In the near future, the amniotic allograft segment of the global soft tissue allografts market is also anticipated to register a highly impressive growth rate during the forecast period. This will be a reflection of increasing number of tissue banks and companies investing in development of new soft tissue allografts from amniotic fluid and tissues. Dental allografts segment is projected to grow with the second best CAGR between 2017 and 2025, gaining traction from the increasing number of incidences of periodontal diseases among young population and rise in technological innovation using dental implants and soft tissue allografts.
There are quite a few end-users connected to the value chain of the global soft tissue allografts market, chiefly bifurcated into hospitals, orthopedic clinics, dental clinics, ambulatory surgical centers, and aesthetic centers. Hospitals accounted for more demand share in 2016 than all other end-users, highlighting the effect of market-favorable-factors such as increasing incidence of diabetic foot ulcers and introduction of technological modification on allografts by key players in the market. Application-wise, wound care is expected to have higher market share by 2025 in comparison to other applications of the soft tissue allografts, including orthopedic and dentistry. The major factors fueling the wound care segment are: increasing incidences of diabetic foot ulcer, incidence of burns and accidents, and increase in spots injuries.
North America Highly Lucrative Region
The global soft tissue allografts market has been segmented into six major regions, viz. North America, Western Europe, Eastern Europe, Asia Pacific, Latin America, and Middle East & Africa. Driven by the developed country of the U.S., North America dominated the global soft tissue allografts market in 2016, due to factors such as increasing prevalence of diabetic foot ulcers, better healthcare awareness program for diabetes and increase in number of surgical procedures on ACL. Furthermore, technological developments on dental implants and increasing expenditure by major key players & small key players for development of soft tissue allografts are also boosting the growth of the soft tissue allografts market in North America.
Allergen, Plc. has been identified as the leading company in the global soft tissue allografts market, whereas some of the other key participants of the market are: Zimmer Biomet, Arthrex, Inc., Lattice Biologics Ltd., Integra LifeSciences Corporation, CONMED Corporation, Organogenesis Inc., Globus Medical Inc, Straumann Holding AG, Osiris Therapeutics, Inc., Xtant Medical, Alliqua BioMedical, Inc, C. R. Bard, Inc (Davol Inc.), and B. Braun Melsungen AG.
Global Soft Tissue Allografts Market: Overview
This report on the soft tissue allografts market analyzes the current and future scenario of the global market. Large number of ACL injury patient and diabetes sufferers is increasing the usage of soft tissue allografts. Increasing prevalence of degenerative joint diseases and high definition designed technology are the major drivers of the global soft tissue allografts market.
The soft tissue allografts market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on soft tissue allograft type, application, end user and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises porters five force analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global soft tissue allografts market.
Global Soft Tissue Allografts Market: Segmentations
Based on soft tissue allograft type, the market has been segmented into cartilage allograft (hyaline cartilage; elastic cartilage; fibro cartilage); tendon allograft (achilles tendon; tibialis; patellar tendon); meniscus allograft; dental allograft (free gingival graft; connective tissue graft; pedicle graft); collagen allograft; amniotic allograft. The soft tissue allograft type market segments have been analyzed based on available approved products, cost-effectiveness, and preference for technologies by orthopaedic, dental & aesthetic surgeons, and patients. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.
Based on end-user, the soft tissue allografts market has been segmented into five major categories: hospitals, ambulatory surgical centers, aesthetic clinics, orthopaedic clinics and dental clinics. The soft tissue allografts market is also segmented into application, including orthopaedic (sports medicine; spine injuries; general Orthopaedic; reconstruction), dentistry (dental sensitivity; aesthetics), wound care, and others. The market segments have been extensively analyzed based on prevalence of the diseases, available treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
Geographically, the global soft tissue allografts market has been categorized into six major regions and the key countries in the respective region: North America (the U.S., Canada), Western Europe (the U.K., Germany, France, Spain, Italy, and Rest of Western Europe), Eastern Europe (Russia, Poland, and Rest of Eastern Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.
Global Soft Tissue Allografts Market: Competitive Landscape
The report also profiles major players in the global soft tissue allografts market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Allergan, plc; Lattice Biologics Ltd.; Zimmer Biomet; AlonSource Group; MiMedix Group; AlloSource; CONMED Corporation; Organogenesis Inc.; RTI Surgical, Inc; Osiris Therapeutics; Integra LifeSciences Corporation; Globus Medical Inc; Straumann Holding AG; Xtant Medical; Alliqua BioMedical, Inc; C. R. Bard, Inc (Davol Inc); B. Braun Melsungen AG; Bone Bank Allograft; Arthrex; and Others.
Global soft tissue allografts market is segmented as below:
- Global Soft Tissue Allografts Market Revenue, by Soft Tissue Allograft Type, (US$ Mn), 2015–2025
- Hyaline Cartilage
- Elastic Cartilage
- Fibro Cartilage
- Tendon Allograft
- Achilles Tendon
- Patellar Tendon
- Meniscus Allograft
- Dental Allograft
- Free Gingival Graft
- Connective Tissue Graft
- Pedicle Graft
- Collagen Allograft
- Amniotic Allograft
- Global Soft Tissue Allografts Market Revenue, by Application, (US$ Mn), 2015–2025
- Sports Medicine
- Spine Injuries
- General Orthopedic
- Dental Sensitivity
- Wound Care
- Global Soft Tissue Allografts Market Revenue, by End-User, (US$ Mn), 2015–2025
- Orthopedic Clinics
- Dental Clinics
- Ambulatory Surgical Centers
- Aesthetic Clinics
- Global Soft Tissue Allografts Market Revenue, By Geography, (US$ Mn), 2015–2025
- North America
- Western Europe
- Rest of Western Europe
- Eastern Europe
- Rest of Eastern Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- GCC countries
- South Africa
- Rest of Middle East & Africa
- North America